Dr. Sura Akram Mohammed is an Iraqi scholar in Clinical Pharmacology with a strong academic background and research profile. She obtained her B.Sc. in Pharmacy from the Baghdad College of Pharmacy in 2010, followed by an M.Sc. in Clinical Pharmacology from the College of Medicine, Al-Mustansiriya University, in 2016. Her master’s research addressed the variability of antiepileptic drug–induced asymptomatic electrocardiographic abnormalities in patients with epilepsy, reflecting her early interest in the interface between pharmacotherapy and cardiovascular safety. She subsequently earned her Ph.D. in Clinical Pharmacology from Al-Nahrain University in 2022, where her doctoral work investigated the anticancer efficacy of Newcastle disease virus and papaverine, both individually and in combination, on mammary adenocarcinoma using integrated in vivo and in vitro experimental models. Professionally, Dr. Sura served at Al-Yarmook Teaching Hospital from 2010 to 2016, progressing from a resident pharmacist to a clinical pharmacist, where she was actively involved in clinical pharmacy services and patient-centered care. Her contributions to healthcare practice were recognized through multiple letters of appreciation issued by the Ministry of Health. She has been a registered member of the Iraqi Pharmacists Syndicate since 2010. Dr. Sura has established a growing research portfolio with publications in peer-reviewed journals, addressing key topics such as the cardiac effects of antiepileptic drugs, the risk of arrhythmias in epileptic patients using advanced electrocardiographic analysis tools, and novel anticancer strategies involving oncolytic viruses and pharmacological agents. Her work demonstrates a multidisciplinary approach that integrates clinical pharmacology, neuroscience, and oncology, with an emphasis on translational and therapeutically relevant research. Additionally, she has participated in professional development programs, including specialized training in English and computer skills, supporting her academic and research activities
